Tag "Johnson & Johnson"

Janssen completes acquisition of investigational Bermekimab

2 years ago 0

The Janssen Pharmaceutical Companies announced the acquisition of all rights to Bermekimab, along with certain employees, from XBiotech Inc., for $750 million. The Janssen Pharmaceutical

BOOK YOUR STAND

Please fill our short form.

    Company Name (required)

    Your Name (required)

    Designation (required)

    Number (required)

    Your Email (required)

    X